CSL Sees Record Drop on Profit Target Cut, New Impairments

Posted 2 hours ago by

Bloomberg

Shares of Australian biotechnology company CSL Ltd. saw the biggest drop on record after it cut its full-year outlook and flagged about 5 billion in additional impairments, saying a turnaround will take longer than expected after a review by its interim chief executive.